ArticleNeurosurgical review2026
Analysis of the correlation between systemic oxidative stress and clinical characteristics for the prognosis in neuroblastoma.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neuroblastoma (NB) is the most prevalent extracranial solid tumor in children, with a survival rate of approximately 50% for those in the high-risk category. Oxidative stress is a well-known contributing factor in various diseases, including cancer; however, the relationship between systemic oxidative stress and the prognosis of NB remains unclear. This study aims to analyze the correlation between oxidative stress and the clinical characteristics of NB, along with its significance for the prognosis of the disease. This study involved 671 NB patients. We analyzed the relationship between systemic oxidative stress and the clinical features or prognosis of NB. A prognostic nomogram was developed based on indicators of systemic oxidative stress, employing Cox regression analysis. To validate the prognostic nomogram for NB, we utilized time-dependent receiver operating characteristics (ROC) curves, calibration curves, and decision curve analysis (DCA). The systematic oxidative stress score (SOS) was developed using three biomarkers of oxidative stress: serum albumin (ALB), total bilirubin (TBIL), and lactate dehydrogenase (LDH). Patients classified in the high SOS group exhibited a poorer prognosis. Multivariate Cox regression analysis indicated that SOS served as an independent prognostic factor for NB. A nomogram incorporating SOS and relevant clinical characteristics demonstrated a high accuracy in predicting the prognosis of NB patients. Furthermore, the results from time-dependent ROC curves, calibration curves, and DCA revealed that the nomogram significantly outperformed traditional prognostic indicators. SOS is identified as an independent prognostic indicator for NB patients. The nomogram incorporating SOS demonstrates potential in predicting outcomes and may provide additional information to support clinical decision-making, but its clinical utility needs independent validation.
Indexed as
Identifiers
42189318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.